About this trial
The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.
Eligibility criteria
Qualifiers
self-identify as Black
smoke cigarettes (greater than or equal to 1 cigarette on greater than or equal to 4 days/week)
motivated to quit smoking
willing to discontinue any non-study smoking cessation pharmacotherapy use during study treatment.
Disqualifiers
currently taking bupropion for non-smoking cessation reasons
Trial design
Treatments tested in this trial
- Nicotine patch
- Quitline Counseling Phone Calls
- Counseling Sessions
- Pathways to Freedom
- Monetary Incentive
Treatment groups
Sponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator